share_log

Canaccord Genuity Maintains Buy on Guardant Health, Lowers Price Target to $30

Canaccord Genuity Maintains Buy on Guardant Health, Lowers Price Target to $30

Canaccord Genuity維持對Guardant Health的買入,將目標價下調至30美元
Benzinga ·  04/29 10:37

Canaccord Genuity analyst Kyle Mikson maintains Guardant Health (NASDAQ:GH) with a Buy and lowers the price target from $45 to $30.

Canaccord Genuity分析師凱爾·米克森維持Guardant Health(納斯達克股票代碼:GH)的買入並將目標股價從45美元下調至30美元。

声明:本內容僅用作提供資訊及教育之目的,不構成對任何特定投資或投資策略的推薦或認可。 更多信息
    搶先評論